Søgeresultater - Mathias Witzens‐Harig

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy

    T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy af Angela M. Krackhardt, Sabine Harig, Mathias Witzens‐Harig, Ryan Broderick, Patrick Barrett, John G. Gribben

    Udgivet 2002
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation

    Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation af Patrick Wuchter, Dan Ran, Thomas Brückner, Thomas Schmitt, Mathias Witzens‐Harig, Kai Neben, Hartmut Goldschmidt, Anthony D. Ho

    Udgivet 2009
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells

    Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells af Nathalie Fiegler, Sonja Textor, Annette Arnold, Alexander Rölle, Ina Oehme, Kai Breuhahn, Gerhard Moldenhauer, Mathias Witzens‐Harig, Adelheid Cerwenka

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX

    Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX af Angela M. Krackhardt, Mathias Witzens‐Harig, Sabine Harig, F. Stephen Hodi, A. Jason Zauls, Morgan Chessia, Patrick Barrett, John G. Gribben

    Udgivet 2002
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma

    Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma af Carmen Choi, Mathias Witzens‐Harig, Marianna Bucur, Markus Feuerer, Nora Sommerfeldt, Andreas Trojan, Anthony D. Ho, Volker Schirrmacher, Hartmut Goldschmidt, Philipp Beckhove

    Udgivet 2004
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials

    Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials af Liat Vidal, Anat Gafter‐Gvili, Gilles Salles, Martin Dreyling, Michele Ghielmini, Shu‐Fang Hsu Schmitz, Ruth Pettengell, Mathias Witzens‐Harig, Ofer Shpilberg

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells

    The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells af Sonja Textor, Felicitas Bossler, Kai-Oliver Henrich, Moritz Gartlgruber, Julia Pollmann, Nathalie Fiegler, Annette Arnold, Frank Westermann, Nina Waldburger, Kai Breuhahn, Sven Golfier, Mathias Witzens‐Harig, Adelheid Cerwenka

    Udgivet 2016
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL

    Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL af Niels Murawski, Michael Pfreundschuh, Samira Zeynalova, Viola Poeschel, Mathias Hänel, Gerhard Held, Norbert Schmitz, Andreas Viardot, Christian Schmidt, Michael Hallek, Mathias Witzens‐Harig, Lorenz Trümper, Torben Rixecker, C. Zwick

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement

    Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement af Gerhard Held, Samira Zeynalova, Niels Murawski, Marita Ziepert, B. Kempf, Andreas Viardot, Martin Dreyling, Michael Hallek, Mathias Witzens‐Harig, Jochen Fleckenstein, Christian Rübe, Carsten Zwick, Bertram Glaß, Norbert Schmitz, Michael Pfreundschuh

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma

    Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma af Georg Heß, Ulrich Keller, Christian W. Scholz, Mathias Witzens‐Harig, J. Atta, Christian Buske, Sebastian Kirschey, Christian Ruckes, Christoph Medler, C. van der Houven van Oordt, Wolfram Klapper, Matthias Theobald, M. Dreyling

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    Erratum to: Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study

    Erratum to: Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study af Mathias Witzens‐Harig, Robin Foà, Alice Di Rocco, Guy van Hazel, Dalton F. Chamone, Jacob M. Rowe, Luca Arcaini, I V Poddubnaya, Anthony D. Ho, Valentina Ivanova, Andrej Vranovský, Dan Thurley, Stephan Oertel

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Errata/Corrigenda
    Føj til favoritter
    Saved in:
  12. 12
    Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group

    Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgk... af Michael Pfreundschuh, Viola Poeschel, Samira Zeynalova, Mathias Hänel, Gerhard Held, Norbert Schmitz, Andreas Viardot, Martin Dreyling, Michael Hallek, Carsten Mueller, Martin H. J. Wiesen, Mathias Witzens‐Harig, Lorenz Truemper, Ulrich Keller, Tanja Rixecker, Carsten Zwick, Niels Murawski

    Udgivet 2014
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  13. 13
    Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

    Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study af Simon Rule, Wojciech Jurczak, Mats Jerkeman, C. Rusconi, Marek Trněný, Fritz Offner, Dolores Caballero, Cristina João, Mathias Witzens‐Harig, Georg Heß, Isabelle Bence‐Bruckler, Seok‐Goo Cho, Catherine Thiéblemont, Wangchi Zhou, Todd Henninger, Judith D. Goldberg, Jessica Vermeulen, Martin Dreyling

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  14. 14
    IBRUTINIB VS TEMSIROLIMUS: THREE‐YEAR FOLLOW‐UP OF PATIENTS WITH PREVIOUSLY TREATED MANTLE CELL LYMPHOMA FROM THE PHASE 3, INTERNATIONAL, RANDOMIZED, OPEN‐LABEL RAY STUDY

    IBRUTINIB VS TEMSIROLIMUS: THREE‐YEAR FOLLOW‐UP OF PATIENTS WITH PREVIOUSLY TREATED MANTLE CELL LYMPHOMA FROM THE PHASE 3, INTERNATIONAL, RANDOMIZED, OPEN‐LABEL RAY STUDY af Simon Rule, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Alves da Silva, C. Rusconi, Marek Trněný, Fritz Offner, Dolores Caballero, Cristina João, Mathias Witzens‐Harig, Georg Heß, I. Bence‐Bruckler, S. Cho, Catherine Thiéblemont, Wangchi Zhou, Todd Henninger, Jeffrey L. Goldberg, Jessica Vermeulen, Martin Dreyling

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  15. 15
    Rituximab With Involved Field Irradiation for Early‐stage Nodal Follicular Lymphoma

    Rituximab With Involved Field Irradiation for Early‐stage Nodal Follicular Lymphoma af Klaus Herfarth, Peter Borchmann, Sven Schnaidt, Karin Hohloch, Volker Budach, M. Engelhard, Andreas Viardot, Rita Engenhart‐Cabillic, Ulrich Keller, Gabriele Reinartz, Hans‐Theodor Eich, Mathias Witzens‐Harig, Clemens F. Hess, Bernd Dörken, Jan Dürig, Thomas Wiegel, Wolfgang Hiddemann, Eva Hoster, Christiane Pott, Martin Dreyling

    Udgivet 2018
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  16. 16
    Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer

    Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung Cancer af Mark Kriegsmann, Christian Haag, Cleo‐Aron Weis, Georg Steinbuß, Arne Warth, Christiane Zgorzelski, Thomas Muley, H. Winter, Martin Eichhorn, Florian Eichhorn, Joerg Kriegsmann, Petros Christopoulos, Michael Thomas, Mathias Witzens‐Harig, Hans‐Peter Sinn, Moritz von Winterfeld, Claus Peter Heußel, Felix J.F. Herth, Frederick Klauschen, Albrecht Stenzinger, Katharina Kriegsmann

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

    Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study af Martin Dreyling, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Marek Trněný, Fritz Offner, Dolores Caballero, Cristina João, Mathias Witzens‐Harig, Georg Heß, Isabelle Bence‐Bruckler, Seok‐Goo Cho, John Bothos, Jeffrey L. Goldberg, Christopher Enny, Shana Traina, Sriram Balasubramanian, Nibedita Bandyopadhyay, Steven Sun, Jessica Vermeulen, Aleksandra Rizo, Simon Rule

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma

    The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma af Niels Weinhold, David C. Johnson, Daniel Chubb, Bowang Chen, Asta Försti, Fay J. Hosking, Peter Broderick, P. Yussanne, Sara E. Dobbins, Dirk Hose, Brian A. Walker, Faith E. Davies, Martin Kaiser, Ni L Li, Walter A. Gregory, Graham Jackson, Mathias Witzens‐Harig, Kai Neben, Per Hoffmann, Markus M. Nöthen, Thomas W. Mühleisen, Lewin Eisele, Fiona M. Ross, Anna Jauch, Hartmut Goldschmidt, Richard S. Houlston, Gareth J. Morgan, Kari Hemminki

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

    Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a rando... af Viola Poeschel, Gerhard Held, Marita Ziepert, Mathias Witzens‐Harig, Harald Holte, Lorenz Thurner, Peter Borchmann, Andreas Viardot, Martin Soekler, Ulrich Keller, Christian Schmidt, Lorenz Truemper, Rolf Mahlberg, Reinhard Marks, Heinz‐Gert Hoeffkes, Bernd Metzner, Judith Dierlamm, Norbert Frickhofen, Mathias Haenel, Andreas Neubauer, Michael Kneba, Francesco Merli, Alessandra Tucci, Peter de Nully Brown, Massimo Federico, Eva Lengfelder, Alice Di Rocco, Ralf Ulrich Trappe, Andreas Rosenwald, Christian Berdel, Martin Maisenhoelder, Ofer Shpilberg, Josif Amam, Konstantinos Christofyllakis, Frank Hartmann, Niels Murawski, Stephan Stilgenbauer, Maike Nickelsen, Gerald Wulf, Bertram Glaß, Norbert Schmitz, Bettina Altmann, Markus Loeffler, Michael Pfreundschuh

    Udgivet 2019
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: